AbbVie
ABBV
ABBV
2,668 hedge funds and large institutions have $133B invested in AbbVie in 2021 Q2 according to their latest regulatory filings, with 161 funds opening new positions, 1,275 increasing their positions, 903 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,668
Holders Change
+64
Holders Change %
+2.46%
% of All Funds
46.58%
Holding in Top 10
139
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+0.72%
% of All Funds
2.43%
New
161
Increased
1,275
Reduced
903
Closed
68
Calls
$2.28B
Puts
$2.36B
Net Calls
-$79.7M
Net Calls Change
+$209M
Top Buyers
| 1 |
Franklin Resources
San Mateo,
California
|
+$830M |
| 2 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$372M |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
+$312M |
| 4 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$268M |
| 5 |
JPMorgan Chase & Co
New York
|
+$146M |
Top Sellers
| 1 |
BlackRock
New York
|
-$453M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$362M |
| 3 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$350M |
| 4 |
Berkshire Hathaway
Omaha,
Nebraska
|
-$264M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$226M |
